Chemical Structure (Image 01)
Chemical structure of nifurtimox, the active ingredient in LAMPIT tablets.*
Lampit Tablet, Film Coated
Product Images NDC 50419-751
14 FDA label images from Bayer Healthcare Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Lampit (NDC 50419-751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
30 mg Tablets (Image 02)
LAMPIT nifurtimox film-coated tablets with an imprint of the number 30 on one side and a score line on the other. The tablets are round and likely represent the 30 mg strength. No packaging or labeler information is visible in the image.*
120 mg Tablets (Image 03)
LAMPIT tablets, film-coated, displaying the imprint '120' on one side and a scored line on the other, corresponding to the 120 mg strength of nifurtimox. The round oral tablets are shown without packaging or labeler information visible in this image.*
Split In Half (Image 04)
An instructional line drawing showing a finger pressing down on a split tablet, demonstrating how to break the tablet into smaller pieces. The illustration focuses on the tablet's scored line and the hand's action to divide it.*
Press (Image 05)
An instructional line drawing showing a human index finger pushing down on a round, film-coated tablet that has a score line. The image demonstrates how to break or split the LAMPIT tablet for dosing.*
Split Tab (Image 06)
A line drawing illustration of a film-coated tablet of LAMPIT (nifurtimox) showing the tablet scored into two halves with one half separated. This image demonstrates the tablet's scoring feature for partial dosing or splitting.*
Spoon W Water (Image 07)
An illustration of an empty spoon viewed from above, showing the bowl and handle in grayscale. No text or branding is visible.*
Spoon W Tablets (Image 08)
An illustration showing a whole tablet and a scored tablet half placed on a spoon, likely demonstrating tablet splitting for oral administration.*
30 mg Label (Image 09)
LAMPIT (nifurtimox) tablets 30 mg, oral use, in a carton label showing a bottle containing 100 film-coated tablets. The label includes manufacturing information by Bayer HealthCare Pharmaceuticals Inc., storage instructions, and a barcode. The product is prescription only, with NDC 50419-750-01.*
120 mg Label (Image 10)
LAMPIT 120 mg nifurtimox tablets label by Bayer HealthCare Pharmaceuticals Inc. The label shows the NDC 50419-751-01, oral route, and package containing 100 film-coated tablets. It includes storage instructions, manufacturing details (Germany), and a description of the tablet strength.*
Tablet In Water (Image 11)
An illustration of a single round, scored film-coated tablet placed on a spoon. The tablet is white or light-colored and is shown with some granules or powder next to it on the spoon.*
Slurry (Image 12)
Illustration showing a spoon containing a semi-solid or liquid substance, possibly indicating a dosage form or administration method related to the product.*
Tablet (Image 13)
LAMPIT 120 mg or 30 mg film-coated oral tablet containing nifurtimox, shown as a round white tablet with a single bisecting score line on one side. Manufactured by Bayer HealthCare Pharmaceuticals Inc.*
Dissolving (Image 14)
An illustration showing a spoon with a small pile of granular or powder-like substance on it. The image likely depicts a dose or measurement related to medication but does not show any text or labeling.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
